US Stock MarketDetailed Quotes
AVTX Avalo Therapeutics
- 12.4100
- -1.0700-7.94%
Close Nov 15 16:00 ET
- 12.4100
- 0.00000.00%
Post 20:01 ET
128.99MMarket Cap0.13P/E (TTM)
13.5000High12.3000Low50.74KVolume13.5000Open13.4800Pre Close651.41KTurnover0.94%Turnover RatioLossP/E (Static)10.39MShares34.460052wk High6.12P/B67.23MFloat Cap3.950152wk Low--Dividend TTM5.42MShs Float22031.7120Historical High--Div YieldTTM8.90%Amplitude3.9501Historical Low12.8370Avg Price1Lot Size
Avalo Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -68.62%-11.53M | -47.68%-16.28M | 38.30%-6.2M | -14.69%-30.68M | 29.80%-2.77M | -219.39%-6.84M | 11.58%-11.03M | 37.44%-10.05M | 62.27%-26.75M | 76.96%-3.94M |
| Net income from continuing operations | 540.65%23.04M | 1,301.79%98.46M | -1,118.38%-121.29M | 24.28%-31.54M | 16.75%-8.17M | -263.78%-5.23M | 36.91%-8.19M | 54.85%-9.96M | 50.63%-41.66M | 48.89%-9.81M |
| Operating gains losses | -34,825.00%-34.93M | -69,425.00%-27.73M | -33.33%120K | -87.65%720K | --600K | ---100K | --40K | --180K | --5.83M | ---- |
| Depreciation and amortization | -17.07%34K | -19.51%33K | 3.03%34K | -4.82%158K | 22.86%43K | 20.59%41K | 36.67%41K | -50.75%33K | -89.98%166K | -88.14%35K |
| Deferred tax | -275.00%-14K | 0.00%7K | -12.50%7K | -50.00%14K | -212.50%-9K | 60.00%8K | 16.67%7K | -11.11%8K | 27.27%28K | 144.44%8K |
| Other non cash items | --0 | -24,799.43%-86.2M | 32,917.43%115.56M | 31.61%1.83M | --0 | 218.93%1.13M | 3.87%349K | 0.00%350K | 74.94%1.39M | 0.00%349K |
| Change In working capital | 58.59%-1.51M | 68.15%-1.33M | 17.07%-1.26M | -15,300.00%-9.24M | 144.04%85K | -358.09%-3.64M | -173.34%-4.16M | -719.11%-1.52M | -102.11%-60K | 54.16%-193K |
| -Change in receivables | 35.41%-965K | -99.75%2K | -90.49%101K | -38.09%1.78M | 331.74%1.4M | -378.73%-1.49M | 52.82%813K | -56.06%1.06M | 795.65%2.88M | 31.79%-605K |
| -Change in inventory | --0 | --0 | --0 | 11.11%20K | --0 | 1,700.00%18K | -50.00%1K | -92.31%1K | 151.43%18K | 109.09%2K |
| -Change in prepaid assets | -518.46%-816K | -392.28%-1.44M | 54.30%-154K | -58.69%447K | 156.40%97K | -74.58%195K | -38.27%492K | -8.71%-337K | 277.00%1.08M | 82.18%-172K |
| -Change in payables and accrued expense | 112.42%301K | 102.47%136K | 47.65%-1.18M | -178.81%-11.48M | -237.49%-1.3M | -648.15%-2.42M | -93.46%-5.5M | -18.90%-2.26M | -201.80%-4.12M | 111.38%947K |
| -Change in other current liabilities | 463.64%80K | 247.06%25K | -1,330.77%-186K | -744.44%-76K | -118.18%-24K | -83.33%-22K | -54.55%-17K | -152.00%-13K | 80.00%-9K | -320.00%-11K |
| -Change in other working capital | ---- | -206.25%-51K | 618.18%158K | -20.45%70K | 75.14%-88K | --88K | --48K | --22K | --88K | ---354K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -68.62%-11.53M | -47.68%-16.28M | 38.30%-6.2M | -14.69%-30.68M | 29.80%-2.77M | -219.39%-6.84M | 11.58%-11.03M | 37.44%-10.05M | 62.27%-26.75M | 76.96%-3.94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 367.67%356K | -40.00%-133K | 0 | 0 | 0 | -133K | 15.93%-95K | 0 |
| Net PPE purchase and sale | --0 | --0 | --0 | 126.32%25K | --0 | --0 | --0 | --25K | 15.93%-95K | --0 |
| Net business purchase and sale | --0 | --0 | --356K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---158K | --0 | --0 | --0 | ---158K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 367.67%356K | -40.00%-133K | --0 | --0 | --0 | ---133K | 15.93%-95K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -178.93%-472K | 690.02%108.61M | 270.37%25.04M | -98.78%1K | 10.7M | 104.05%598K | 13.75M | -113.77%-14.7M | 7.89%82K |
| Net issuance payments of debt | --0 | ---- | ---- | ---21.24M | --0 | ---15.24M | ---- | ---- | --0 | --14.81M |
| Net common stock issuance | --0 | --0 | 741.03%115.63M | 412.88%46.22M | 100.01%1K | --25.94M | --6.53M | --13.75M | -120.54%-14.77M | -17,914.63%-14.77M |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | -8.22%67K | --0 | --0 | ---- | ---- | -96.22%73K | -69.62%48K |
| Net other financing activities | --0 | ---472K | ---7.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -178.93%-472K | 690.02%108.61M | 270.37%25.04M | -98.78%1K | --10.7M | 104.05%598K | --13.75M | -113.77%-14.7M | 7.89%82K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,349.82%93.56M | 553.47%110.31M | -43.34%7.55M | -75.72%13.32M | -39.97%10.31M | -43.84%6.45M | -56.49%16.88M | -75.72%13.32M | 187.15%54.86M | -76.11%17.18M |
| Current changes in cash | -398.70%-11.53M | -60.67%-16.76M | 2,784.25%102.77M | 86.11%-5.77M | 28.33%-2.77M | -32.14%3.86M | 61.81%-10.43M | 122.18%3.56M | -216.19%-41.55M | 77.35%-3.86M |
| End cash Position | 695.48%82.03M | 1,349.82%93.56M | 553.47%110.31M | -43.33%7.55M | -43.33%7.55M | -39.97%10.31M | -43.84%6.45M | -56.49%16.88M | -75.72%13.32M | -75.72%13.32M |
| Free cash flow | -68.62%-11.53M | -47.68%-16.28M | 38.30%-6.2M | -14.28%-30.68M | 29.80%-2.77M | -220.20%-6.84M | 11.98%-11.03M | 37.44%-10.05M | 62.19%-26.85M | 76.97%-3.94M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data